组织扩张器乳房再造术后血清肿:结局与管理
回顾性分析138例患者共219侧组织扩张器乳房再造,28侧(12.8%)发生血清肿,75侧(34.2%)引流时间延长。血清肿在淋巴结手术、延期再造和胸肌前再造者中更常见;抽吸是最常见干预(85.7%)。作者建议避免引流超过3周,并在拔管后筛查积液。
要点
- 219侧组织扩张器乳房再造中28侧(12.8%)发生血清肿。
- 淋巴结手术、延期再造、胸肌前再造与血清肿发生相关。
- 抽吸是最常见干预(85.7%),经扩张器注射座在门诊完成。
核心结论
- 作者建议避免引流管留置超过3周,并在拔除引流管后筛查积液。
- 经扩张器注射座系列抽吸并继续扩张是处理血清肿的安全有效方法,可避免感染和扩张器丢失。
研究设计与样本
- 经IRB批准的乳房再造数据库回顾性分析,纳入接受组织扩张器再造的患者,记录患者特征、手术细节、结局和治疗。
- 共138例患者、219侧组织扩张器乳房再造。
主要发现
- 28侧再造发生血清肿(12.8%),75侧引流时间延长(34.2%)。
- 血清肿在淋巴结手术(P = 0.043)、延期再造(P = 0.049)和胸肌前再造(P = 0.002)患者中更常见。
- 血清肿和/或引流时间延长在体重指数较高(P = 0.044)和乳房较大(P = 0.001)的患者中更常见。
- 抽吸是最常见干预(85.7%),在门诊利用扩张器注射座完成。
- 血清肿患者与无血清肿患者的感染率(P = 0.546)和取出率(P = 0.167)无差异;而任何积液问题(血清肿和/或引流延长)患者更易发生感染(P = 0.041)和接受取出(P < 0.005)。
关键数值与推荐
- 血清肿发生率12.8%(28/219侧)。
- 引流时间延长发生率34.2%(75/219侧)。
- 抽吸干预占85.7%。
临床怎么用
- 作者建议避免引流管留置超过3周。
- 作者建议拔除引流管后筛查积液。
- 经扩张器注射座系列抽吸并继续扩张用于处理血清肿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seroma is a relatively common complication after breast reconstruction with tissue expanders. The main risk in the presence of seroma is development of periprosthetic infection, which can lead to implant loss. Our goals were to identify risk factors for seroma, and to describe our protocol for managing fluid accumulation. PATIENTS AND METHODS: An IRB approved breast reconstruction database was reviewed to identify patients who underwent tissue expander reconstruction. Patient characteristics, details of surgery, outcomes and treatment were recorded. RESULTS: Two hundred nineteen tissue expander reconstructions were performed in 138 patients. Twenty-eight reconstructions developed seroma (12.8%), and 75 were identified to have prolonged drains (34.2%). Seroma was more common in patients with lymph node surgery ( P = 0.043), delayed reconstruction ( P = 0.049), and prepectoral reconstruction ( P = 0.002). Seroma and/or prolonged drains were more commonly noted in patients with higher body mass index ( P = 0.044) and larger breast size ( P = 0.001). Aspiration was the most common intervention (85.7%), which was performed in the clinic utilizing the expander port site. There was no difference in infection or explantation rate between seroma and no-seroma patients ( P = 0.546 and 0.167), whereas patients with any fluid concern (seroma and/or prolonged drains) were more prone to developing infection and undergoing explantation ( P = 0.041 and P < 0.005). CONCLUSION: We recommend that prolonged drain placement longer than 3 weeks should be avoided, and patients should be screened for fluid accumulation after drain removal. Serial aspiration via expander port site and continuation of expansion provide a safe and effective method to manage seromas to avoid infection and expander loss. BACKGROUND: Seroma is a relatively common complication after breast reconstruction with tissue expanders. The main risk in the presence of seroma is development of periprosthetic infection, which can lead to implant loss. Our goals were to identify risk factors for seroma, and to describe our protocol for managing fluid accumulation. PATIENTS AND METHODS: An IRB approved breast reconstruction database was reviewed to identify patients who underwent tissue expander reconstruction. Patient characteristics, details of surgery, outcomes and treatment were recorded. RESULTS: Two hundred nineteen tissue expander reconstructions were performed in 138 patients. Twenty-eight reconstructions developed seroma (12.8%), and 75 were identified to have prolonged drains (34.2%). Seroma was more common in patients with lymph node surgery ( P = 0.043), delayed reconstruction ( P = 0.049), and prepectoral reconstruction ( P = 0.002). Seroma and/or prolonged drains were more commonly noted in patients with higher body mass index ( P = 0.044) and larger breast size ( P = 0.001). Aspiration was the most common intervention (85.7%), which was performed in the clinic utilizing the expander port site. There was no difference in infection or explantation rate between seroma and no-seroma patients ( P = 0.546 and 0.167), whereas patients with any fluid concern (seroma and/or prolonged drains) were more prone to developing infection and undergoing explantation ( P = 0.041 and P < 0.005). CONCLUSION: We recommend that prolonged drain placement longer than 3 weeks should be avoided, and patients should be screened for fluid accumulation after drain removal. Serial aspiration via expander port site and continuation of expansion provide a safe and effective method to manage seromas to avoid infection and expander loss.
引用
- Ozturk CN, Ozturk C, Magner WJ, et al. Seroma After Breast Reconstruction With Tissue Expanders: Outcomes and Management. Ann Plast Surg. 2023. PMID: 37347178. doi:10.1097/SAP.0000000000003573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。